Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Methicillin-resistant Staphylococcus Aureus
Interventions
DRUG

Retapamulin

Retapamulin ointment, 1%, apply a thin layer, BID for 5 days

Trial Locations (2)

70112

Tulane University School of Medicine, New Orleans

70121

Ochsner Health System, New Orleans

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Tulane University School of Medicine

OTHER

collaborator

GlaxoSmithKline

INDUSTRY

lead

Ochsner Health System

OTHER